CBZ delivered extraordinary financial growth with revenue surging 311% and operating income up 217%, while simultaneously reducing its outstanding share count by 3.7 million shares.
The massive revenue increase combined with strong profitability growth suggests either a transformational acquisition (evidenced by references to the Marcum LLP acquisition) or exceptional organic growth that has fundamentally scaled the business. The reduction in outstanding shares from 53.8M to 50.1M indicates significant share repurchase activity, which amplifies per-share earnings growth and demonstrates strong capital allocation discipline during a period of rapid expansion.
CBZ experienced transformational growth across all key metrics, with revenue exploding 311% to $922M and operating income surging 217% to $234M, indicating successful scaling and operational leverage. Net income grew 181% to $115.4M while operating cash flow increased a more modest 55.6% to $192.5M, suggesting strong earnings quality despite the rapid expansion. The company maintained financial discipline with measured increases in capital expenditure (31%) and cash position (32%), while the dramatic revenue growth combined with proportionally smaller operating cash flow increases signals this was likely driven by a major acquisition rather than purely organic growth.
Strong top-line growth of 311.2% — accelerating demand or successful expansion into new markets.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Net income grew 181.3% — bottom-line growth signals improving overall business health.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Operating cash flow surged 55.6% — exceptional cash generation, highest quality earnings signal.
Cash position surged 32.3% — strong cash generation or capital raise providing significant financial cushion.
Capital expenditure jumped 31.3% — major investment cycle underway; assess returns on deployment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →